Attic (middle ear) cholesteatoma - Symptoms, Causes, Treatment & Prevention

📅 Updated: June 2026 ⏱ 8 min read ✅ Medically reviewed
```html Attic (Middle Ear) Cholesteatoma – Comprehensive Medical Guide

Attic (Middle Ear) Cholesteatoma – A Complete Patient Guide

Overview

Attic cholesteatoma, also called a pars flaccida or “middle‑ear cholesteatoma,” is an abnormal, non‑cancerous growth of keratinizing squamous epithelium (skin cells) that develops in the attic (upper) portion of the middle ear behind the eardrum. Over time, the collection of dead skin, oil, and debris expands, eroding the delicate bone around the middle ear, the inner ear, and even the skull base.

Who it affects: The condition is most common in children and adolescents, but adults can develop it as a result of chronic ear disease or previous ear surgery. Epidemiological data indicate:

  • Incidence in the United States: ~12 cases per 100,000 people per year (CDC, 2022).
  • Peak age of diagnosis: 5–15 years for congenital/chronic‑ear forms; 30–50 years for acquired adult forms.
  • Male‑to‑female ratio ≈ 1.2 : 1.

The disease is rare in populations with excellent access to routine otologic care, but prevalence rises in regions where chronic otitis media is untreated.

Symptoms

Symptoms vary depending on the size of the cholesteatoma and how much surrounding tissue has been damaged. Below is a comprehensive list:

Ear‑related symptoms

  • Persistent otorrhea (draining fluid from the ear) – usually foul‑smelling, watery or purulent.
  • Hearing loss – typically conductive (due to ossicle erosion), but can become mixed or sensorineural if the inner ear is involved.
  • Fullness or pressure in the ear, often described as “blocked.”
  • Tinnitus – ringing, buzzing, or hissing sounds.
  • Ear pain (otalgia) – may be intermittent and can mimic middle‑ear infection.
  • Visible white or yellowish debris behind the tympanic membrane when examined.

Balance‑related symptoms

  • Dizziness or vertigo – when the cholesteatoma reaches the vestibular apparatus.
  • Unsteady gait or a sensation that the room is spinning.

Neurologic and facial symptoms (late signs)

  • Facial weakness or asymmetry (due to facial nerve involvement).
  • Headaches or ear‑radiating pain from local bone erosion.
  • Ear discharge turning bloody – indicates possible erosion into a blood vessel.

Because symptoms often mimic chronic ear infections, many patients are initially treated for otitis media before a cholesteatoma is identified.

Causes and Risk Factors

Attic cholesteatoma is classified as either congenital (present at birth) or acquired**.

Congenital

  • Result of epithelial tissue trapped in the middle ear during embryologic development.
  • Usually detected in early childhood when the child presents with persistent otorrhea or hearing loss.

Acquired (most common)

Acquired cholesteatoma develops when normal middle‑ear ventilation is disrupted, allowing squamous epithelium from the external ear canal to migrate into the middle ear. Key mechanisms include:

  • Chronic otitis media with tympanic membrane retraction – negative pressure pulls the thin pars flaccida into the attic.
  • Eustachian tube dysfunction – common in allergies, upper‑respiratory infections, and adenoid hypertrophy.
  • Repeated ear infections – especially in children with frequent middle‑ear effusions.
  • Previous ear surgery (e.g., tympanostomy tubes) – can create a pathway for keratinizing epithelium.
  • Trauma or perforation of the tympanic membrane – provides a portal for skin cells.

Risk factors

  • Age < 18 years (congenital or childhood‑acquired forms).
  • History of recurrent otitis media or chronic middle‑ear effusion.
  • Allergic rhinitis, asthma, or other conditions causing persistent nasopharyngeal inflammation.
  • Down syndrome or craniofacial anomalies that affect Eustachian tube anatomy.
  • Living in areas with limited access to primary otolaryngology care.
  • Smoking exposure (secondhand smoke) – impairs mucociliary clearance.

Diagnosis

Accurate diagnosis requires a combination of clinical examination and imaging studies.

Otoscopic Examination

  • Use of a handheld otoscope or a microscope reveals a retracted pars flaccida with a pear‑shaped, keratin‑filled sac (the “cholesteatoma mass”).
  • Active ear discharge, granulation tissue, or a “white pearl” behind the tympanic membrane are classic clues.

Tympanometry

Provides information about middle‑ear pressure and compliance, often showing a type B (flat) curve in the presence of a large cholesteatoma.

Audiometry

A pure‑tone audiogram quantifies the degree and type of hearing loss. Conductive loss greater than 30 dB is common.

Imaging

  • High‑resolution computed tomography (HRCT) of the temporal bone – gold standard for assessing bone erosion, extent of disease, and surgical planning.
  • Magnetic resonance imaging (MRI) with diffusion‑weighted sequences – helps differentiate cholesteatoma from granulation tissue or effusion (cholesteatoma shows high signal on DWI).

Other Tests (selected cases)

  • Electro‑cochleography – to evaluate inner‑ear function if vertigo is present.
  • Facial nerve EMG – when facial weakness is suspected.

Diagnosis is usually confirmed by an otolaryngologist (ENT) and staged according to the extent of disease (e.g., the “EAONO/JOS” staging system).

Treatment Options

Because cholesteatoma is progressive and destructive, definitive surgical removal is the mainstay of treatment. Non‑surgical measures are limited to adjunctive care.

Medical Management (Adjunct)

  • Topical or oral antibiotics – treat secondary infection and reduce discharge but do not eradicate the cholesteatoma itself.
  • Ear cleaning (aural toileting) – performed by a clinician to remove debris and decrease bacterial load.
  • Control of Eustachian tube dysfunction – nasal steroids, antihistamines, or saline irrigations may improve middle‑ear ventilation.

Surgical Procedures

1. Canal Wall Up (CWU) Mastoidectomy

  • Preserves the posterior ear canal wall, maintaining ear canal anatomy.
  • Ideal for limited disease without extensive mastoid involvement.
  • May require a second “second‑look” surgery (6–12 months later) to ensure no residual disease.

2. Canal Wall Down (CWD) Mastoidectomy

  • Removes the posterior canal wall, creating an open cavity that is easier to inspect and clean.
  • Recommended for extensive disease, large cholesteatomas, or when there is significant mastoid erosion.
  • Patients must learn lifelong cavity care (daily cleaning, periodic suction polishing).

3. Minimal Invasive Endoscopic Ear Surgery

  • Uses a rigid endoscope through the ear canal to excise small cholesteatomas without mastoidectomy.
  • Increasingly popular for early‑stage disease (Stage I‑II).

4. Reconstruction (Ossiculoplasty & Tympanoplasty)

  • After removal, the ossicles (tiny hearing bones) may be repaired or replaced with prostheses to improve hearing.
  • Cartilage or temporalis fascia grafts are often used to reconstruct the tympanic membrane.

Post‑operative Care

  • Head‑up positioning for 48 hours to reduce swelling.
  • Antibiotic ear drops for 1–2 weeks if the ear canal is packed.
  • Regular follow‑up visits with otoscopic exam and audiometry at 3, 6, and 12 months.
  • For CWD cavities, daily cleaning with a soft suction tip and periodic debridement by an ENT specialist.

Lifestyle & Supportive Measures

  • Avoid water exposure (use ear plugs while swimming) during the healing phase.
  • Manage allergies and upper‑respiratory infections promptly.
  • Quit smoking and limit exposure to second‑hand smoke.
  • Use a humidifier in dry environments to keep mucosa moist.

Living with Attic (Middle Ear) Cholesteatoma

Even after successful surgery, ongoing care is essential to preserve hearing and prevent recurrence.

Daily Management Tips

  • Ear Hygiene – keep the outer ear clean; never insert cotton swabs or objects.
  • Cavity Care (for CWD patients) – irrigate the cavity with prescribed saline solution and suction any debris each evening.
  • Hearing Protection – use earmuffs or custom‑fitted earplugs in noisy environments to protect the rebuilt middle ear.
  • Monitor for Changes – any new discharge, pain, hearing drop, or facial weakness should prompt immediate contact with your ENT.
  • Stay Up‑to‑Date on Vaccinations – especially flu and pneumococcal vaccines that reduce respiratory infections.

Follow‑up Schedule

  1. First post‑op visit: 1 week (wound check, pack removal).
  2. 3‑month visit: otoscopic exam + audiogram.
  3. 6‑month and 12‑month visits: repeat imaging (CT or MRI) if there were concerns for residual disease.
  4. Yearly lifelong surveillance – most recurrences occur within the first 5 years, but late recurrences have been reported up to 15 years later (Mayo Clinic, 2021).

Psychosocial Aspects

Hearing loss can affect school performance and social interaction, particularly in children. Early involvement of speech‑language therapists, audiologists, and school counselors can mitigate these impacts.

Prevention

While congenital cholesteatoma cannot be prevented, acquired forms are largely avoidable with proper ear health.

  • Prompt treatment of acute otitis media – complete prescribed antibiotic courses when indicated.
  • Regular ENT check‑ups for children with chronic ear disease – early detection of tympanic membrane retraction.
  • Control allergic rhinitis and sinus disease – use intranasal steroids or antihistamines to reduce Eustachian tube blockage.
  • Avoid prolonged use of cotton‑tip applicators – they can push cerumen deeper and irritate the canal.
  • Limit exposure to loud noises – using hearing protection helps preserve the repaired middle ear.

Complications

If left untreated, cholesteatoma can cause serious, sometimes life‑threatening complications.

  • Hearing loss – progressive conductive loss that may become permanent sensorineural loss.
  • Facial nerve palsy – due to erosion of the facial nerve canal.
  • Labyrinthine fistula – abnormal opening into the inner ear causing vertigo and profound hearing loss.
  • Mastoiditis – infection of the mastoid air cells, potentially spreading to the brain.
  • Brain abscess or meningitis – rare but severe intracranial infections.
  • Sinus thrombosis – clot formation in the sigmoid sinus from chronic infection.
  • Rare malignant transformation – cholesteatoma is benign, but chronic inflammation can predispose to squamous cell carcinoma (<1 % of cases).

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you experience any of the following:
  • Sudden, severe ear pain that does not improve with analgesics.
  • Rapidly increasing drainage that becomes bright red or contains blood.
  • Sudden loss of hearing in the affected ear.
  • High‑fever (> 38.5 °C / 101.3 °F) with ear discharge.
  • Facial droop, weakness, or difficulty closing the eye on the same side as the ear problem.
  • Episodes of intense vertigo or imbalance accompanied by nausea/vomiting.
  • Swelling behind the ear or on the side of the neck that is tender to touch.
These signs may indicate an infection that is spreading beyond the middle ear (mastoiditis, intracranial involvement) and require urgent intravenous antibiotics and possible surgical drainage.

References

```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References